Hormone receptor positive breast tumor

A hormone-receptor-positive (HR+) tumor is a tumor which consists of cells that express receptors for certain hormones. The term most commonly refers to estrogen receptor positive estrogen receptor positive tumors  (i.e. tumors that contain estrogen receptor positive cells), but can also include progesterone receptor positive tumors. Estrogen-receptor-positive tumors depend on the presence of estrogen for ongoing proliferation.

 

 

  • Lowering systemic levels of estrogen.
  • Achieved by the use of drugs from the aromatase inhibitor category.
  • Blockage of the estrogen receptors on the cancerous cells
  • Treating hematological malignancies such as lymphoma and leukemia (cancers)
  • The science of blood transfusion and the work of a blood bank

Related Conference of Hormone receptor positive breast tumor

October 27-28, 2025

14th International Conference on Herbal Medicine and Acupuncture

Amsterdam, Netherlands
November 03-04, 2025

5th World Medicine Congress

Rome, Italy
November 21-22, 2025

5th International Conference on Medical Research and Development

Amsterdam, Netherlands
November 25-26, 2025

21st World Summit on Blockchain Technology

Amsterdam, Netherlands
March 09-10, 2026

13th World Machine Learning and Deep learning Conference

Singapore City, Singapore
March 26-27, 2026

12th World Congress on Anesthesia and Critical Care

Amsterdam, Netherlands
April 20-21, 2026

47th International Summit on Human Anatomy & Physiology

Barcelona, Spain
May 18-19, 2026

16th Annual Congress on Clinical and Medical Case Reports

Aix-en-Provence, France
October 19-20, 2026

12th World Congress on Medicinal Plants and Marine Drugs

Aix-en-Provence, France

Hormone receptor positive breast tumor Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in